Published on September 07, 2017

MFH and MPH Earn ACR Accreditation for Stereotactic Breast Biopsy

Darby, PA (September 7, 2017): Mercy Fitzgerald and Mercy Philadelphia have been awarded a three-year accreditation in Stereotactic Breast Biopsy by the American College of Radiology (ACR). 

This is the third consecutive accreditation for Mercy Philadelphia, and the second accreditation for Mercy Fitzgerald. 

A breast biopsy is performed to remove cells—either surgically or through a less invasive procedure involving a hollow needle—from an area in the breast suspected to be cancerous. These cells are examined under a microscope to determine a diagnosis. In stereotactic breast biopsy, a special mammography machine helps guide the radiologist’s instruments to the site of the abnormal growth.

The ACR gold seal of accreditation represents the highest level of image quality and patient safety. It is awarded only to facilities meeting ACR Practice Parameters and Technical Standards after a peer-review evaluation by board-certified physicians and medical physicists who are experts in the field. Image quality, personnel qualifications, adequacy of facility equipment, quality control procedures and quality assurance programs are assessed. The findings are reported to the ACR Committee on Accreditation, which subsequently provides the practice with a comprehensive report that can be used for continuous practice improvement.

“The commitment of our mammography colleagues to providing exceptional care to our patients and the community is inspiring,” said José Missri, MD, FACC, FACP, Vice President of Medical Affairs at Mercy Fitzgerald and Mercy Philadelphia. “We are so pleased to receive these accreditations again from the American College of Radiology.”